興科蓉醫藥：環境、社會及管治報告2024.pdf

1、2024ENVIRONMENTAL,SOCIAL AND GOVERNANCE REPORT 環境、社會及管治報告12024年環境、社會及管治報告 興科蓉醫藥控股有限公司Environmental,Social and Governance Report環境、社會及管治報告關於本報告編輯依據本環境、社會及管治報告（本報告）詳細描述興科蓉醫藥控股有限公司及其所有附屬公司（合稱 本集團或 我們）的環境、社會及管治（ESG）表現。本報告根據上市規則附錄C2所載香港聯合交易所（港交所）環境、社會及管治報告指引 編寫，並依循 不遵守就解釋 的條文要求對相關事項進行闡述，同時設立符合 環境、社會及管治報告

2、指引 所規定環境與社會關鍵績效指標進行表現檢討。本報告所引用的數據及信息源於本集團各項問卷、記錄、統計和研究。報告原則本報告遵循 環境、社會及管治報告指引 所載的四項基本報告原則，具體如下：Reporting PrinciplesApplication報告原則應用情況MaterialityThe Report covers the key environmental and social concerns from different stakeholders1.These material environmental and social issues were identified thr

3、ough deliberation by the Board and the audit committee,discussion between the Board and the management and engagement with different stakeholders.Identification processes of material sustainability issues and the materiality matrix of sustainability issues are disclosed in the Report.Further details

4、 are set out in the“Stakeholder Engagement”and“Materiality Assessment”sections.重要性本報告涵蓋涉及不同持份者1的主要環境及社會事宜。該等重大環境及社會事宜已通過董事會及審核委員會的審議、董事會與管理層的討論及與不同持份者的溝通確定。重大可持續議題的識別過程以及重大可持續議題矩陣在本報告披露，其進一步詳情載於 持份者參與 及重要性評估 章節。QuantitativeThe Report discloses information on the standards,methodologies,assumptions a

5、nd/or calculation used,and source of key emission and conversion factors used for both quantitative environmental and social KPIs,details of which are explained in the explanatory notes under the KPIs section.量化本報告披露有關量化環境及社會關鍵績效指標所用標準、方法、假設及或計算方法、關鍵排放來源及轉換因素信息，詳情均於關鍵績效指標章節的註釋說明進行解釋。BalanceThe Repor

6、t presents the Groups ESG performance and discloses sustainability related matters in an unbiased way,without omission of any relevant negative information and details or overstatement of any positive news or impacts.The Report was prepared in an objective manner to avoid improper information disclo